ColonView Quick Test
Ideal tools for colorectal cancer screening
ColonView lateral flow quick test is intended for simple detection of fecal occult blood (FOB) in stool samples. The test is based on highly sensitive immunochemical detection of hemoglobin and hemoglobin/haptoglobin complex. The principal use of the Biohit ColonView Hb and Hb/Hp test is to screen for lower gastrointestinal (GI) pathologies, such as colorectal cancers and large adenomas that bleed. With the combination of two biomarkers, the ColonView quick test detects bleeding derived from both lower and upper gastrointestinal tract.
Test kit includes: The ColonView tests come in packs of 30 tests, each including test cassettes and well-equipped Sample Collection Kits that are given to the patient for home sample collection. Each collection kit includes a single Sample Collection Tube, instructions for use and a handy Stool Collection Paper. The same sample can be used for both Hb and Hb/Hp testing. ColonView Hb and Hb/Hp tests are simple, one step lateral flow tests that give results in 15 minutes.
- Excellent screening tool for colorectal cancer and large adenomas that bleed
- Combined detection of hemoglobin (Hb) and hemoglobin/haptoglobin (Hb/Hp) complex
- Detects bleeding from both lower and upper gastrointestinal tract
- User-friendly Sample Collection Kit
- Quick and simple single-step lateral flow test
- 2-in-1 test cassette
- High sensitivity for fecal occult blood detection
- No dietary restrictions
N.B In the USA and Japan for research use only. For other countries, please check with your local Biohit distributor.
Quick test reader
The ColonView QT result can be confirmed with the help of the Biohit Quick test reader. Read more about this product from the Instruments pages.
ColonView Hb and Hb/Hp Fecal Occult Blood Test (FOB) test was designed to aid diagnosis of lower GI pathologies, such as colorectal cancers and large adenomas that bleed. Colorectal cancer is one of the most commonly diagnosed cancers and a leading cause of cancer death in the United States. Screening for colorectal cancer probably increases the cancer detection rate at an early stage, therefore reducing the mortality.